ISSN: 2332-0877

Journal of Infectious Diseases & Therapy
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Commentary   
  • J Infect Dis Ther, Vol 11(5)
  • DOI: 10.4172/2332-0877.1000554

Infection-Induced cAMP-Independent Regulation of Protein Kinase A (PKA)

Malak Haidar1 and Gordon Langsley2*
1de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
2Université Paris Cité, CNRS, INSERM, Institut Cochin, Paris, Belgium
*Corresponding Author: Gordon Langsley, Université Paris Cité, CNRS, INSERM, Institut Cochin, Paris, France, Email: gordon.langsley@inserm.fr

Received: 06-Dec-2023 / Manuscript No. JIDT-23-101483 / Editor assigned: 08-Dec-2023 / PreQC No. JIDT-23-101483 (PQ) / Reviewed: 22-Jun-2023 / QC No. JIDT-23-101483 / Revised: 29-Jun-2023 / Manuscript No. JIDT-23-101483 (R) / Published Date: 06-Jul-2023 DOI: 10.4172/2332-0877.1000554

Abstract

The regulation of cellular signaling pathways is crucial for maintaining cellular equilibrium and coordinating responses to parasite infections. Protein Kinase A (PKA) is a key player in cellular signaling involved in regulating these processes. Apicomplexa parasites, including Plasmodium falciparum and Theileria annulata, exploit PKA to promote infection-induced pathogenesis. In this commentary, we describe two alternative
mechanisms employed by these medically important parasites to regulate Protein Kinase A (PKA) activity independent of fluxes in cyclic Adenosine Monophosphate (cAMP). Epigenetic regulation of PRKAR2B expression not only bypasses traditional cAMP-dependent regulation of PKA activity, but in doing so also provides new therapeutic targets for the potential treatment of malaria and tropical theileriosis.

Keywords: miR-34c; PRKAR2B; cAMP; Theileria; Plasmodium

Description

The regulation of cellular signaling pathways is vital for maintaining cellular equilibrium and coordinating appropriate responses to environmental stresses, including parasite infection. Protein Kinase A (PKA) plays a key role in modulating cellular signaling by controlling various cellular processes such as metabolism, gene expression, cell growth, and differentiation [1]. Apicomplexa parasites, which include species like Plasmodium falciparum (causative agent of pernicious human malaria), Toxoplasma gondii (causing toxoplasmosis), and Theileria annulata (causing tropical theileriosis), employ PKA to promote infection-induced pathogenesis [2].

PKA is a cytosolic holoenzyme composed of two catalytic subunits and two regulatory subunits that are classically regulated by fluxes in cAMP [3]. Under basal conditions, regulatory subunits are bound to catalytic subunits, maintaining PKA activity in an inactive state. Upon cAMP binding to regulatory subunits, a conformational change occurs leading to the release and activation of catalytic subunits. However, T. annulata exploits a unique strategy to bypass the cAMPdependent regulation of PKA activity. In this commentary, we provide a brief description of the mechanism employed by Theileria and Plasmodium to regulate PKA activity independently of changes in cAMP fluxes and discuss its implications in the pathophysiology of tropical theileriosis and malaria [4].

Infection-induced cAMP-independent regulation of PKA

miRNAs are small, non-coding RNA molecules that regulate gene expression by binding to the target messenger RNAs (mRNAs) inhibiting their translation or promoting their degradation. They exhibit a wide range of functions in various physiological and pathological conditions [5]. miR-34c-3p is a specific member of a microRNA family known as miR-34c and infection of bovine leukocytes by T. annulata induces upregulation of miR-34c-3p levels [4]. miR-34c-3p directly targets and degrades the type II-beta regulatory subunit (prkar2b) leading to reduced expression of the inhibitory subunit and increased PKA activity in T. annulata-infected leukocytes. As a result, the disseminating tumor-like phenotype of T. annulata-transformed macrophages is enhanced. Similarly, P. falciparum infection of red blood cells induces augmentation in miR-34c-3p levels, provoking degradation of residual red blood cell prkar2b and enhancing PKA activity [4]. Infection-induced increase in miR-34c-3p levels, therefore, provides a novel epigenetic mechanism for regulating host cell PKA activity independent of cAMP fluxes to aggravate tumor dissemination and improve parasite fitness.

Theileria infection also regulates leukocyte PKA activity in second way independent of cAMP. PKI γ is a member of the Protein Kinase A Inhibitor (PKIs) family that regulates PKA activity by acting as a pseudo-substrate that binds to and deactivates C-subunits. In Theileria-infected and transformed disseminating macrophages PKI γ levels are typically low, and associated with tumor virulence [5,6]. However, long-term culture of Theileria-transformed macrophages leads to dampening of their dissemination potential and these cell lines are used as attenuated vaccines against tropical theileriosis [7]. Attenuation of virulence results in elevated PKI γ expression, reduced PKA activity, and diminished infected macrophage dissemination [6]. This again highlights a non-cAMP mechanism employed by Theileria annulata to manipulate host PKA activity to promote infected leukocyte pathogenicity.

Significance and implications

The important role that PKA plays in the pathogenesis of Plasmodium, due to its regulation of red blood cell and parasite protein phosphorylation, as well as intra-erythrocyte development, is well known; reviewed in [8]. Moreover, the contribution of PKA to the survival and tumorigenic phenotype of T. annulata-infected leukocytes is well documented; reviewed in [2]. The recent identification of prkar2b as a target gene of miR-34c-3p uncovered a novel mechanism for regulating mammalian PKA activity, and provides a new and potential therapeutic target for the treatment of malaria and tropical theileriosis [4].

Conclusion

By shedding light on a cAMP-independent pathway for PKA activation and revealing a novel mechanism for parasite manipulation of host cell signaling, epigenetic regulation of PKA activity opens up new avenues for therapeutic intervention and calls for a deeper understanding of the different mechanisms underlying alternative modes of PKA activation and their functional implications in cellular physiology and disease pathogenesis.

Acknowledgment

We thank all co-authors of the original paper describing infection induced epigenetic regulation of PKA activity by miR-34c.

References

Citation: Haidar M, Langsley G (2023) Infection-Induced cAMP-Independent Regulation of Protein Kinase A (PKA). J Infect Dis Ther 11: 554. DOI: 10.4172/2332-0877.1000554

Copyright: © 2023 Haidar M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted  use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top